For patients not prescribed GLP-1 receptor agonists at 6-month follow-up, despite eConsult recommendations, the reasons for not prescribing or for discontinuing the medication included side effects, low BMI, history of pancreatitis, patient preference to avoid injection, allergy, and cost limitations. The gene discussed is GLP1R; the disease is allergic disease.